Back to KROS
FEDERATED HERMES, INC. KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$7.7M
Q3 2026
Peak value
$13.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $131K |
| Q4 2025 | $13.2M |
| Q1 2026 | $172K |
| Q1 2026 | $7.4M |
| Q2 2026 | $268K |
| Q2 2026 | $7.2M |
| Q3 2026 | $351K |
| Q3 2026 | $7.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.7M | 676.3K | — | — |
| Q3 2026 | $351K | 30.8K | — | — |
| Q2 2026 | $7.2M | 675.4K | — | — |
| Q2 2026 | $268K | 25.1K | — | — |
| Q1 2026 | $7.4M | 673.6K | — | — |
| Q1 2026 | $172K | 15.6K | — | — |
| Q4 2025 | $13.2M | 648.3K | — | — |
| Q4 2025 | $131K | 6.4K | — | — |